InChI=1S/C27H40O4/c1- 17(30)31-23-14-22-25(4)12-7-11-24(2,3)20(25)10-13-26(22,5)21-9-8-18(15-28)19(16-29)27(21,23)6/h8,15-16,19-23H,7,9-14H2,1-6H3/t19-,20-,21-,22+,23-,25-,26-,27+/m0/s1 |
| ADWFEADZGIHPDE-QGERINELSA-N |
| [H]C(=O)[C@H]1C(=CC[C@@]2([H])[C@]3(C)CC[C@@]4([H])C(C)(C)CCC[C@]4(C)[C@@]3([H])C[C@H](OC(C)=O)[C@]12C)C([H])=O |
|
|
Cacospongia mollior
(NCBI:txid1162743)
|
See:
DOI
|
|
Hypomontagnella monticulosa
(NCBI:txid2487000)
|
of strain
Zg15SU
See:
PubMed
|
|
Spongia officinalis
(NCBI:txid252964)
|
Diethyl ether soluble portion of acetone extract of chopped, frozen sponge.
See:
PubMed
|
|
Glossodoris rufomarginata
(NCBI:txid508147)
|
See:
PubMed
|
|
marine metabolite
Any metabolite produced during a metabolic reaction in marine macro- and microorganisms.
animal metabolite
Any eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
EC 3.1.1.4 (phospholipase A2) inhibitor
An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of phospholipase A2 (EC 3.1.1.4).
TRP channel blocker
An agent that inhibits the passage of cations through the transient receptor potential (TRP) channels.
|
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
|
|
|
(4aS,4bR,6S,6aS,7R,10aS,10bR,12aS)-7,8-diformyl-1,1,4a,6a,10b-pentamethyl-1,2,3,4,4a,4b,5,6,6a,7,10,10a,10b,11,12,12a-hexadecahydrochrysen-6-yl acetate
|
